Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02207855 · ClinicalTrials.gov registry record

Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants

A clinical trial of Anesthesia, sponsored by Joseph D. Tobias.

Completed
Registry status
21
Enrollment target
1
Study location

NCT02207855: Completed study of Anesthesia, sponsored by Joseph D. Tobias.

NCT02207855 is a study of Anesthesia that has completed, run by Joseph D. Tobias. The registered enrollment target is 21 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02207855, a study of Anesthesia, has completed, sponsored by Joseph D. Tobias.

COMPLETED
Registry status
21 participants
Enrollment target
1
Study location

Study Summary

This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

Conditions Studied

Interventions

  • DRUG Chloroprocaine

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2014-06
Est. Completion 2015-03
Joseph D. Tobias

21 total trials

What the finished NCT02207855 record still lists

NCT02207855 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Chloroprocaine is the first listed.

NCT02207855 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02207855 about?

NCT02207855 is a clinical study titled "Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants". This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

What is the current status of trial NCT02207855?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2014-06. Estimated completion is 2015-03.

What conditions does trial NCT02207855 study?

This clinical trial studies the following conditions: Anesthesia.

What interventions are being tested in trial NCT02207855?

The interventions under investigation include: Chloroprocaine (DRUG).

Who is sponsoring clinical trial NCT02207855?

This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02207855 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02207855's enrollment target sits among peer trials

21 50th of 57 higher than 8 of 57 other Anesthesia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02207855, the US trial registry maintained by the National Library of Medicine. NCT02207855 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.